Schrödinger has announced a strategic collaboration and software agreement with Bristol Myers Squibb (BMS) to deploy Bunsen, its agentic AI co-scientist, within BMS’s research organization. The agreement builds on a long-standing partnership in which BMS routinely uses Schrödinger’s computational platform. Bunsen combines AI with physics-based simulation and is designed to plan and run complex molecular discovery workflows, then interpret the results.
Schrödinger will work with BMS scientists to develop new Bunsen functionality alongside its computational technologies for large-scale chemical exploration and RetroSynth, its AI-driven synthesis planning platform. The collaboration aims to help scientists explore chemical possibilities, prioritize molecules with greater confidence and guide discovery decisions before experimental testing.
Image generated by: ChatGPT
